Ang Li Wei, Kam Yiu Wing, Lin Cui, Krishnan Prabha Unny, Tay Joanne, Ng Lee Ching, James Lyn, Lee Vernon J M, Goh Kee Tai, Ng Lisa F P, Lin Raymond T P
Public Health Group, Ministry of Health, Singapore.
Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore.
PLoS Negl Trop Dis. 2017 Dec 27;11(12):e0006163. doi: 10.1371/journal.pntd.0006163. eCollection 2017 Dec.
We determined the seroprevalence of chikungunya virus (CHIKV) infection in the adult resident population in Singapore following local outbreaks of chikungunya fever (CHIKF) in 2008-2009.
Our cross-sectional study involved residual sera from 3,293 adults aged 18-79 years who had participated in the National Health Survey in 2010. Sera were tested for IgG antibodies against CHIKV and dengue virus (DENV) and neutralizing antibodies against CHIKV.
The prevalence of CHIKV-neutralizing antibodies among Singapore residents aged 18-79 years was 1.9% (95% confidence interval: 1.4%- 2.3%). The CHIKV seroprevalence was highest in the elderly aged 70-79 years at 11.5%, followed by those aged 30-39 years at 3.1%. Men had significantly higher CHIKV seroprevalence than women (2.5% versus 1.3%, p = 0.01). Among the three main ethnic groups, Indians had the highest seroprevalence (3.5%) compared to Chinese (1.6%) and Malays (0.7%) (p = 0.02 and p = 0.01, respectively). Multivariable logistic regression identified adults aged 30-39 years and 70-79 years, men, those of Indian ethnicity and ethnic minority groups, and residence on ground floor of public and private housing apartments as factors that were significantly associated with a higher likelihood of exposure to CHIKV. The overall prevalence of anti-DENV IgG antibodies was 56.8% (95% CI: 55.1%- 58.5%), while 1.5% (95% CI: 1.1%- 2.0%) of adults possessed both neutralizing antibodies against CHIKV and IgG antibodies against DENV.
Singapore remains highly susceptible to CHIKV infection. There is a need to maintain a high degree of vigilance through disease surveillance and vector control. Findings from such serological study, when conducted on a regular periodic basis, could supplement surveillance to provide insights on CHIKV circulation in at-risk population.
在2008 - 2009年新加坡本地基孔肯雅热(CHIKF)爆发后,我们确定了新加坡成年常住人口中基孔肯雅病毒(CHIKV)感染的血清流行率。
我们的横断面研究涉及2010年参加全国健康调查的3293名年龄在18 - 79岁的成年人的剩余血清。检测血清中针对CHIKV和登革病毒(DENV)的IgG抗体以及针对CHIKV的中和抗体。
18 - 79岁新加坡居民中CHIKV中和抗体的流行率为1.9%(95%置信区间:1.4% - 2.3%)。CHIKV血清流行率在70 - 79岁的老年人中最高,为11.5%,其次是30 - 39岁的人群,为3.1%。男性的CHIKV血清流行率显著高于女性(2.5%对1.3%,p = 0.01)。在三个主要种族群体中,印度人的血清流行率最高(3.5%),而华人(1.6%)和马来人(0.7%)较低(分别为p = 0.02和p = 0.01)。多变量逻辑回归确定,30 - 39岁和70 - 79岁的成年人、男性、印度族裔和少数族裔群体以及居住在公共和私人住房公寓底层的居民是与接触CHIKV可能性较高显著相关的因素。抗DENV IgG抗体的总体流行率为56.8%(95% CI:55.1% - 58.5%),而1.5%(95% CI:1.1% - 2.0%)的成年人同时拥有针对CHIKV的中和抗体和针对DENV的IgG抗体。
新加坡对CHIKV感染仍高度易感。需要通过疾病监测和病媒控制保持高度警惕。定期进行此类血清学研究的结果可补充监测,以提供关于高危人群中CHIKV传播情况的见解。